Antígeno nuclear de proliferación celular (PCNA) como factor pronóstico en tumor de Wilms
Palabras clave:
-Resumen
-
Citas
Ries LAG. Smith MA,Gurney JG. Et al., eds. Cancer incidence and survival among chlldren and adolescente: United States SEER Program 1975-1995. National Cancer Institute, SEER Program. NIKI Publication No. 99-4649, Bethesda, MD, 1999
Bonaitl-Pellie C. Chornpret A, Tournade ME, et al. Genetics and epidemiology of Wilms' tumor: the French Wilms' Tumor Study. Med Pediatr Oncol 1992:20:284.
Denys P. Malvaux P. Van Den Berghe H. Tanghe W. Proesrnans W. Association d'un syndrome anatomo-pathologique de pseudohermaphroditism masculin, d'une Tumeur de Wilms. d'une nephropathie parenchymateuse et d'un mosaicisrn XX hXY. Arch Fr Pediatr 1967;24:729.
Coppes MJ, Huff V, Pelletier J. Denys-Drash syndrome: relating a clinical disorder to genetic alterations in the tumor suppressor gene
WT1. J Pediatr 1993:123:673.
Green DM. Diagnosis and management solid turnors in infants and children. Boston: Martinus Níjhoff, 1985.
Murphy WM, Beckwith JB. Farrow GM. Atlas of tumor pathology. 3rd Series, fascicle 11. Tumors of the kidney, bladder. and related urinary structures. Washington, DC: Armed Forces Institute of Pathology, 1994
Breslow NE, Beckwith JB. Cid M. Sharples K. Age distribution of Wilms turnar: report from the National Wilms Tumor Study. Cancer Res 1988;48:1653.
Breslow N, Churchill G. Beckwith JB. et al. Prognosis for Wilms' tumor patients with nonmetastatic disease at diagnosis--results of the Second National Wilms' Tumor Study. J Clin Oncol 1985,3:521.
Breslow N, Sharples K, Beckwith JB, et al. Prognosis in nonmetastatic. favorable histology Wilms' tumor: results of the Third National Wilms' Tumor Study. Cancer 1991;68:2345,
Ambros R" Trost R.: Inmunohistochemical localizaban of metailothionien in human breast cancer. Anticancer Research, May-june; 19(39:2133-9. 199909-21
Hans Huber. Citalogia. Histologie und rnikroskopische Anatomie des Menschen. Aufi, Verlag. Bern, Stuttgart. Wien , 1997
Khine MM, Aung W, Sibbons PD. Howard CV. Clapham E. McGill F. Van Velzen D. Analysis ofretative proliferation rates of Wilms' tumor components using proliferating cell nuclear antigen and MIB-1 (Ki67 equivalent antigen) immunostaining and assessment of mitotic index. Department of Fetal and Infant Pathology, University of Liverpool, United Kingdom. Lab Invest 1994 Jan:70(1):125-9.
Nagoshi M, Tsuneyoshi M. Expression of proliferating celI nuclear antigen in Wilms' tumors and other pediatric renal tumors: the correlation between histologic classification and proliferative activity_ Second Department of Pathology, Kyushu University. Fukuoka, Japan. J Surg Oncol 1994 Feb:55(2):114-21
Chen F, Liu G, Zhang Z, Li Z. Cai W. Expression of proliferating cell nuclear antigen in Wilms' tumor. Department of Pediatric Surgery. Xin Hua Hospital, Shanghai Second Medical University, China. 236: Chin Med J (Engl) 1997 May;110(5):352-3 15.Delahunt B, Farrant GJ. Bethwaite PB. Nacey JN, Lewis ME. Assessment of proliferative activíty in Wilms' tumour. Department of Pathology, Wellington School of Medicine, New Zealand. Anal Cell Pathol 1994 Aug;7(2):127-38 .
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2005 Cristóbal flavanzo C., Emilio Crovo Y., Fernando Ti rapegui S., Dr. José Schalper P.
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
